Cargando…

Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy

Immunotherapy has become the breakthrough strategies for treatment of cancer in recent years. The application of messenger RNA in cancer immunotherapy is gaining tremendous popularity as mRNA can function as an effective vector for the delivery of therapeutic antibodies on immune targets. The high e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duan, Li-Juan, Wang, Qian, Zhang, Cuilian, Yang, Dong-Xiao, Zhang, Xu-Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196868/ https://www.ncbi.nlm.nih.gov/pubmed/35711457 http://dx.doi.org/10.3389/fimmu.2022.923647

Ejemplares similares

mRNA vaccines for cancer immunotherapy
por: Vishweshwaraiah, Yashavantha L., et al.
Publicado: (2022)

mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy
por: Deng, Zhuoya, et al.
Publicado: (2022)

Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
por: Hu, Chaoying, et al.
Publicado: (2023)

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
por: Wang, Bolin, et al.
Publicado: (2023)

Advances in mRNA Vaccines for Infectious Diseases
por: Zhang, Cuiling, et al.
Publicado: (2019)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
por: Wang, Yang, et al.
Publicado: (2021)

Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development
por: Lin, Han, et al.
Publicado: (2022)

Construction and immunogenicity of an mRNA vaccine against chikungunya virus
por: Liu, Jingjing, et al.
Publicado: (2023)

Influenza Viruses: Innate Immunity and mRNA Vaccines
por: Lee, SangJoon, et al.
Publicado: (2021)

mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
por: Xu, Ziyang, et al.
Publicado: (2023)

A novel mRNA vaccine, SYS6006, against SARS-CoV-2
por: Xu, Ke, et al.
Publicado: (2023)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine
por: Zhong, Hua, et al.
Publicado: (2021)

Advancing mRNA technologies for therapies and vaccines: An African context
por: Kairuz, Dylan, et al.
Publicado: (2022)

A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice
por: Bai, Shimeng, et al.
Publicado: (2023)

Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases
por: Yang, Lu, et al.
Publicado: (2022)

How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development
por: Duan, Qiongyu, et al.
Publicado: (2022)

An mRNA vaccine against rabies provides strong and durable protection in mice
por: Li, Miao, et al.
Publicado: (2023)

Immunization with a novel mRNA vaccine, TGGT1_216200 mRNA-LNP, prolongs survival time in BALB/c mice against acute toxoplasmosis
por: Zhang, Yizhuo, et al.
Publicado: (2023)

Analysis of lncRNA and mRNA Repertoires in Lung From BAFF-R-Deficient Pneumocystis-Infected Mice
por: Rong, Heng-Mo, et al.
Publicado: (2022)

Corrigendum: A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice
por: Bai, Shimeng, et al.
Publicado: (2023)

Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
por: Liu, Shaojun, et al.
Publicado: (2023)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
por: You, Weiqiang, et al.
Publicado: (2022)

mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV
por: Matarazzo, Laura, et al.
Publicado: (2023)

Integrated Analysis of circRNA-miRNA-mRNA Regulatory Networks in the Intestine of Sebastes schlegelii Following Edwardsiella tarda Challenge
por: Cao, Min, et al.
Publicado: (2021)

Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine
por: Sun, Zhuolun, et al.
Publicado: (2023)

Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer
por: Zhang, Xin, et al.
Publicado: (2022)

The potential regulatory role of the lncRNA-miRNA-mRNA axis in teleost fish
por: Zhou, Zhixia, et al.
Publicado: (2023)

Literature Mining and Mechanistic Graphical Modelling to Improve mRNA Vaccine Platforms
por: Leonardelli, Lorena, et al.
Publicado: (2021)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

mRNA delivery in cancer immunotherapy
por: Zhong, Yichen, et al.
Publicado: (2023)

Screening for diagnostic targets in tuberculosis and study on its pathogenic mechanism based on mRNA sequencing technology and miRNA-mRNA-pathway regulatory network
por: Yang, Yue, et al.
Publicado: (2023)

Design and preclinical evaluation of a universal SARS-CoV-2 mRNA vaccine
por: Qin, Jane, et al.
Publicado: (2023)

mRNA cancer vaccines: Advances, trends and challenges
por: He, Qing, et al.
Publicado: (2022)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Analyses of circRNA and mRNA Profiles in Vogt–Koyanagi–Harada Disease
por: Shu, Jia, et al.
Publicado: (2021)

Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination
por: Sisteré-Oró, Marta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6d6m94ikk5g4q5bacrlbgkuek5